HomeNewsBusinessMoneycontrol ResearchAnother great quarter for Dr Reddy’s, but is it sustainable?

Another great quarter for Dr Reddy’s, but is it sustainable?

EMs are expected to remain the chief driver of top-line growth, driven by chronic therapies and biosimilars

Anubhav Sahu

January 27, 2023 / 10:02 IST

Another great quarter for Dr Reddy’s, but is it sustainable?

As competition with peers heats up and exclusivity with regard to few strengths would end in Q1FY24, we believe sales traction from g-Revlimid will moderate over the next few quarters

Watch Webinar

PRO Panorama

Moneycontrol Pro Panorama | Oil market shakeup

Sep 8, 2025 / 03:21 PM IST

For September 8 edition of Moneycontrol Pro Panorama: RBI framework can be a gamechanger for Indian fintechs, decline in employmen...
Read Now
PRO Weekender

Moneycontrol Pro Weekender | GST in Gloriously Silly Terms

Sep 6, 2025 / 10:00 AM IST

GST saw a Glorious Structural Turnaround this week and many other acronyms
Read Now

Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More